A 38-year-old woman undergoes surgical resection for a WHO Grade II diffuse astrocytoma of the left temporal lobe. Postoperative MRI confirms gross total resection. Molecular testing shows IDH1 mutation and 1p/19q codeletion. She is referred for adjuvant therapy. What is the drug of choice for chemotherapy in this patient?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.